Fig. 2From: Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expressionBlue dots represent the patients in the lowest tTSSTRE group (values < 5000 (SUV x mL), n = 106). Green dots represent the patients in the medium tTSSTRE group (values 5000–15,000 (SUV x mL), n = 56). Brown dots represent the patients in the largest tTSSTRE group (values > 15,000 (SUV x mL), n = 41). The blue, green and red lines represent the fitted line for the peptide values of each tTSSTRE group. a Regression analyses whereby the mean tumor absorbed dose is plotted against the administered amount of peptide at the first PRRT cycle in respect to the patient`s total tumor somatostatin receptor expression (tTSSTRE). b Correlation between amount of administered peptide and the tumor-to-kidney absorbed dose ratio, with respect to the total tumor somatostatin receptor expression (tTSSTRE). c Correlation between amount of administered peptide (µg) and the tumor-to-liver absorbed dose ratio, with respect to the total tumor somatostatin receptor expression (tTSSTRE). d Correlation between amount of administered peptide (µg) and the tumor-to-spleen absorbed dose ratio, with respect to the total tumor somatostatin receptor expression (tTSSTRE). e Correlation between amount of administered peptide and the mean kidney absorbed dose with respect to the total tumor somatostatin receptor expression (tTSSTRE)Back to article page